The uptake of high-deductible health plans (HDHPs) has accelerated with the state and federal health exchanges under Obamacare. The out-of-pocket costs of these plans, including premium payments, are “consuming far more of total family income than is reasonable,” says Francois de Brantes, executive director of the Healthcare Incentives Improvement. A dilemma, he comments, is that HDHPs are the only way to get premiums down to a level of affordability for many individuals. He believes that until the industry is fully transformed, “It’s not going to get better.”
“It is popular to argue against mandates of any kind,” stresses Arthur Vercillo, MD, FACS, regional president of Excellus Blue Cross Blue Shield, but he strongly recommends that the premiums people pay buy them what amounts to some real insurance—a meaningful minimum benefit package that insurance covers.
Affordability is the key issue, reiterates Mr de Brantes. If the premiums and out-of-pocket costs are 20 to 30% of family income, that’s not affordable or workable.
Large out-of-pocket costs can have negative health consequences, acknowledges Ateev Mehrotra, MD, MPH, associate professor of healthcare policy and medicine at Harvard Medical School and a hospitalist at Beth Israel Deaconess Medical Center. This is especially true for the poor, the elderly, and those with chronic illnesses. In addition, prices for care vary greatly and prospective patients need much more information and transparency about medical care pricing if they are to make intelligent decisions regarding their out-of-pocket costs.
One added advantage that is often overlooked, points out Dr Vercillo, is that when an individual is insured by an exchange plan, they are already getting a negotiated rate for care that is substantially better than what someone without insurance might have to pay.
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Mental Health Diagnoses, Care Challenges Rise Among US Youth, Report Finds
April 26th 2024While behavioral health care utilization has been rising, the treatment landscape has been worsening. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial behavioral health diagnosis.
Read More